Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression

Antioxidants and Redox Signaling

Volumn 26, Issue 11, 2017, Pages 563-582

  Klein, Diana ^a   Steens, Jennifer ^a   Wiesemann, Alina ^a   Schulz, Florian ^a   Kaschani, Farnusch ^a   Röck, Katharina ^b   Yamaguchi, Masahiro ^c   Wirsdörfer, Florian ^a   Kaiser, Markus ^a   Fischer, Jens W ^b   Stuschke, Martin ^a   Jendrossek, Verena ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

mesenchymal stem cell therapy; radioprotection; Radiotherapy; vascular dysfunction

Indexed keywords

BETA ACTIN; COBALT 60; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; FIBRONECTIN; NESTIN; TRANSGELIN; VASCULAR ENDOTHELIAL CADHERIN; EUK-134; ORGANOMETALLIC COMPOUND; SALICYLIC ACID DERIVATIVE;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME INDUCTION; EXPERIMENTAL PULMONARY FIBROSIS; FEMALE; IRRADIATION; ISOLATED LUNG; LONG TERM SURVIVAL; LUNG ENDOTHELIUM; LUNG FIBROBLAST; LUNG PARENCHYMA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION PNEUMONIA; RADIATION PROTECTION; STEM CELL CULTURE; WHOLE THORAX IRRADIATION; ANIMAL; CYTOLOGY; DISEASE MODEL; EXPERIMENTAL RADIATION INJURY; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENETICS; LUNG; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHENOTYPE; RADIATION INJURIES; RADIATION RESPONSE; ULTRASTRUCTURE;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBROBLASTS; FIBROSIS; GENE EXPRESSION; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; ORGANOMETALLIC COMPOUNDS; PHENOTYPE; RADIATION INJURIES; RADIATION INJURIES, EXPERIMENTAL; SALICYLATES; SUPEROXIDE DISMUTASE-1;

EID: 85017327829     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6748     Document Type: Article

References (87)

1. Almeida C, Nagarajan D, Tian J, Leal SW, Wheeler K, Munley M, Blackstock W, and Zhao W. The role of alveolar epithelium in radiation-induced lung injury. PLoS One 8: e53628, 2013.
2. Ashcroft T, Simpson JM, and Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41: 467-470, 1988.
3. Azzam EI, Jay-Gerin JP, and Pain D. Ionizing radiationinduced metabolic oxidative stress and prolonged cell injury. Cancer Lett 327: 48-60, 2012.
4. Benderitter M, Caviggioli F, Chapel A, Coppes RP, Guha C, Klinger M, Malard O, Stewart F, Tamarat R, Luijk PV, and Limoli CL. Stem cell therapies for the treatment of radiation-induced normal tissue side effects. Antioxid Redox Signal 21: 338-355, 2014.
5. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 6: 702-713, 2006.
6. Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AM, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HP, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HM, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, and Zollo M. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol 35 Suppl: S276-S304, 2015.
7. Borst GR, Ishikawa M, Nijkamp J, Hauptmann M, Shirato H, Onimaru R, van den Heuvel MM, Belderbos J, Lebesque JV, and Sonke JJ. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol 91: 307-313, 2009.
8. Caplan AI and Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084, 2006.
9. Cappuccini F, Eldh T, Bruder D, Gereke M, Jastrow H, Schulze-Osthoff K, Fischer U, Kohler D, Stuschke M, and Jendrossek V. New insights into the molecular pathology of radiation-induced pneumopathy. Radiother Oncol 101: 86-92, 2011.
10. Chen C, Yang S, Zhang M, Zhang Z, Hong J, Han D, Ma J, Zhang SB, Okunieff P, and Zhang L. Triptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts. Cancer Biol Ther 17: 381-389, 2016.
11. Chow K, Fessel JP, Kaoriihida S, Schmidt EP, Gaskill C, Alvarez D, Graham B, Harrison DG, Wagner DH, Jr., Nozik-Grayck E, West JD, Klemm DJ, and Majka SM. Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling. Pulm Circ 3: 31-49, 2013.
12. Coggle JE, Lambert BE, and Moores SR. Radiation effects in the lung. Environ Health Perspect 70: 261-291, 1986.
13. Conese M, Carbone A, Castellani S, and Di Gioia S. Paracrine effects and heterogeneity of marrow-derived stem/ progenitor cells: Relevance for the treatment of respiratory diseases. Cells Tissues Organs 197: 445-473, 2013.
14. Coppes RP, van der Goot A, and Lombaert IM. Stem cell therapy to reduce radiation-induced normal tissue damage. Semin Radiat Oncol 19: 112-121, 2009.
15. Corre I, Guillonneau M, and Paris F. Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity. Int J Mol Sci 14: 22678-22696, 2013.
16. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, and Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13: 2513-2526, 2014.
17. Cox J and Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372, 2008.
18. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, and Mann M. Andromeda: A peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1794-1805, 2011.
19. Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 10: 355-370, 2008.
20. Declercq L, Sente I, Hellemans L, Corstjens H, and Maes D. Use of the synthetic superoxide dismutase/catalase mimetic EUK-134 to compensate for seasonal antioxidant deficiency by reducing pre-existing lipid peroxides at the human skin surface. Int J Cosmet Sci 26: 255-263, 2004.
21. Dimmeler S, Hermann C, Galle J, and Zeiher AM. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 19: 656-664, 1999.
22. Ding NH, Li JJ, and Sun LQ. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets 14: 1347-1356, 2013.
23. Dong F and Caplan AI. Cell transplantation as an initiator of endogenous stem cell-based tissue repair. Curr Opin Organ Transplant 17: 670-674, 2012.
24. Down JD and Yanch JC. Identifying the high radiosensitivity of the lungs of C57L mice in a model of total-body irradiation and bone marrow transplantation. Radiat Res 174: 258-263, 2010.
25. Eldh T, Heinzelmann F, Velalakan A, Budach W, Belka C, and Jendrossek V. Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are timeand dose-dependent. Strahlenther Onkol 188: 274-281, 2012.
26. Ergun S, Tilki D, and Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal 15: 981-995, 2011.
27. Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 44: 13-22, 2005.
28. Fukai T and Ushio-Fukai M. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15: 1583-1606, 2011.
29. Gao F, Fish BL, Szabo A, Doctrow SR, Kma L, Molthen RC, Moulder JE, Jacobs ER, and Medhora M. Short-term treatment with a SOD/catalase mimetic, EUK-207, mitigates pneumonitis and fibrosis after single-dose total-body or whole-thoracic irradiation. Radiat Res 178: 468-480, 2012.
30. Gao F, Kinnula VL, Myllarniemi M, and Oury TD. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 10: 343-354, 2008.
31. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, and Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159, 2003.
32. Ghafoori P, Marks LB, Vujaskovic Z, and Kelsey CR. Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 22: 37-47; discussion 52-53, 2008.
33. Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, Faber H, Niemantsverdriet M, Brandenburg S, Berger RM, Langendijk JA, Coppes RP, and van Luijk P. Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 84: e639-e646, 2012.
34. Ghosh SN, Wu Q, Mader M, Fish BL, Moulder JE, Jacobs ER, Medhora M, and Molthen RC. Vascular injury after whole thoracic x-ray irradiation in the rat. Int J Radiat Oncol Biol Phys 74: 192-199, 2009.
35. Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, van Rooijen N, Haslett C, Howie SE, Simpson AJ, Hirani N, Gauldie J, Iredale JP, Sethi T, and Forbes SJ. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med 184: 569-581, 2011.
36. Gnecchi M, Zhang Z, Ni A, and Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219, 2008.
37. Graves PR, Siddiqui F, Anscher MS, and Movsas B. Radiation pulmonary toxicity: From mechanisms to management. Semin Radiat Oncol 20: 201-207, 2010.
38. Guckenberger M, Baier K, Polat B, Richter A, Krieger T, Wilbert J, Mueller G, and Flentje M. Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 97: 65-70, 2010.
39. Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Torchia EC, Childs C, Shade T, Tadjali M, Lara A, Nozik-Grayck E, Malkoski S, Sorrentino B, Meyrick B, Klemm D, Rojas M, Wagner DH, Jr., and Majka SM. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells 29: 725-735, 2011.
40. Kelsey CR, Horwitz ME, Chino JP, Craciunescu O, Steffey B, Folz RJ, Chao NJ, Rizzieri DA, and Marks LB. Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. Int J Radiat Oncol Biol Phys 81: 812-818, 2011.
41. Kishaba Y, Matsubara D, and Niki T. Heterogeneous expression of nestin in myofibroblasts of various human tissues. Pathol Int 60: 378-385, 2010.
42. Klein D. Vascular wall-resident multipotent stem cells of mesenchymal nature within the process of vascular remodeling: Cellular basis, clinical relevance, and implications for stem cell therapy. Stem Cells Int 2016: 1905846, 2016.
43. Klein D, Meissner N, Kleff V, Jastrow H, Yamaguchi M, Ergun S, and Jendrossek V. Nestin(+) tissue-resident multipotent stem cells contribute to tumor progression by differentiating into pericytes and smooth muscle cells resulting in blood vessel remodeling. Front Oncol 4: 169, 2014.
44. Klein D, Schmetter A, Imsak R, Wirsdorfer F, Unger K, Jastrow H, Stuschke M, and Jendrossek V. Therapy with multipotent mesenchymal stromal cells protects lungs from radiation-induced injury and reduces the risk of lung metastasis. Antioxid Redox Signal 24: 53-69, 2016.
45. Klein D, Schmitz T, Verhelst V, Panic A, Schenck M, Reis H, Drab M, Sak A, Herskind C, Maier P, and Jendrossek V. Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors. Oncogenesis 4: e148, 2015.
46. Koukourakis MI. Radiation damage and radioprotectants: New concepts in the era of molecular medicine. Br J Radiol 85: 313-330, 2012.
47. Lakhdar R, Denden S, Kassab A, Leban N, Knani J, Lefranc G, Miled A, Chibani JB, and Khelil AH. Update in chronic obstructive pulmonary disease: Role of antioxidant and metabolizing gene polymorphisms. Exp Lung Res 37: 364-375, 2011.
48. Langan AR, Khan MA, Yeung IW, Van Dyk J, and Hill RP. Partial volume rat lung irradiation: The protective/mitigating effects of Eukarion-189, a superoxide dismutasecatalase mimetic. Radiother Oncol 79: 231-238, 2006.
49. Mahmood J, Jelveh S, Calveley V, Zaidi A, Doctrow SR, and Hill RP. Mitigation of radiation-induced lung injury by genistein and EUK-207. Int J Radiat Biol 87: 889-901, 2011.
50. Maiolica A, Borsotti D, and Rappsilber J. Self-made frits for nanoscale columns in proteomics. Proteomics 5: 3847-3850, 2005.
51. Makinde AY, John-Aryankalayil M, Palayoor ST, Cerna D, and Coleman CN. Radiation survivors: Understanding and exploiting the phenotype following fractionated radiation therapy. Mol Cancer Res 11: 5-12, 2013.
52. Marriott S, Baskir RS, Gaskill C, Menon S, Carrier EJ, Williams J, Talati M, Helm K, Alford CE, Kropski JA, Loyd J, Wheeler L, Johnson J, Austin E, Nozik-Grayck E, Meyrick B, West JD, Klemm DJ, and Majka SM. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. Am J Physiol Cell Physiol 307: C684-C698, 2014.
53. Martin J, Helm K, Ruegg P, Varella-Garcia M, Burnham E, and Majka S. Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 10: 140-151, 2008.
54. McNultyKand Janes SM. Stem cells and pulmonary fibrosis: Cause or cure? Proc Am Thorac Soc 9: 164-171, 2012.
55. McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, and Bertoncello I. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 27: 623-633, 2009.
56. Michalski A, Damoc E, Lange O, Denisov E, Nolting D, Muller M, Viner R, Schwartz J, Remes P, Belford M, Dunyach JJ, Cox J, Horning S, Mann M, and Makarov A. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol Cell Proteomics 11: O111.013698, 2012.
57. Milliat F, Francois A, Tamarat R, and Benderitter M. Role of endothelium in radiation-induced normal tissue damages [French]. Ann Cardiol Angeiol (Paris) 57: 139-148, 2008.
58. Moulder JE and Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 17: 141-148, 2007.
59. Niki E. Antioxidants: Basic principles, emerging concepts, and problems. Biomed J 37: 106-111, 2014.
60. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S, and Mann M. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4: 2010-2021, 2005.
61. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, and Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297, 2001.
62. Park MT, Oh ET, Song MJ, Lee H, and Park HJ. Radiosensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs. J Radiat Res 53: 570-580, 2012.
63. Pilling D and Gomer RH. Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice. PLoS One 9: e93730, 2014.
64. Prasanna SJ, Gopalakrishnan D, Shankar SR, and Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5: e9016, 2010.
65. Reddy SP. The antioxidant response element and oxidative stress modifiers in airway diseases. Curr Mol Med 8: 376-383, 2008.
66. Ribeiro A, Laranjeira P, Mendes S, Velada I, Leite C, Andrade P, Santos F, Henriques A, Graos M, Cardoso CM, Martinho A, Pais M, da Silva CL, Cabral J, Trindade H, and Paiva A. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther 4: 125, 2013.
67. Rolandsson S, Andersson Sjoland A, Brune JC, Li H, Kassem M, Mertens F, Westergren A, Eriksson L, Hansson L, Skog I, Bjermer L, Scheding S, and Westergren-Thorsson G. Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissueresident cells. BMJ Open Respir Res 1: e000027, 2014.
68. Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmood J, Medhora M, Molthen R, Moulder JE, Sonis ST, Tofilon PJ, and Doctrow SR. Salen Mn complexes mitigate radiation injury in normal tissues. Anticancer Agents Med Chem 11: 359-372, 2011.
69. Rube CE, Uthe D, Wilfert F, Ludwig D, Yang K, Konig J, Palm J, Schuck A, Willich N, Remberger K, and Rube C. The bronchiolar epithelium as a prominent source of proinflammatory cytokines after lung irradiation. Int J Radiat Oncol Biol Phys 61: 1482-1492, 2005.
70. Scobioala S, Klocke R, Kuhlmann M, Tian W, Hasib L, Milting H, Koenig S, Stelljes M, El-Banayosy A, Tenderich G, Michel G, Breithardt G, and Nikol S. Up-regulation of nestin in the infarcted myocardium potentially indicates differentiation of resident cardiac stem cells into various lineages including cardiomyocytes. FASEB J 22: 1021-1031, 2008.
71. Shah MH, Liu GS, Thompson EW, Dusting GJ, and Peshavariya HM. Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells. Breast Cancer Res Treat 150: 523-534, 2015.
72. Siani A and Tirelli N. Myofibroblast differentiation: Main features, biomedical relevance, and the role of reactive oxygen species. Antioxid Redox Signal 21: 768-785, 2014.
73. Sinclair KA, Yerkovich ST, Chen T, McQualter JL, Hopkins PM, Wells CA, and Chambers DC. Mesenchymal stromal cells are readily recoverable from lung tissue, but not the alveolar space, in healthy humans. Stem Cells 2016 [Epub ahead of print]; DOI: 10.1002/stem.2419.
74. Stenmark KR, Fagan KA, and Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99: 675-691, 2006.
75. Stewart DJ and Mei SH. Cell-based therapies for lung vascular diseases: Lessons for the future. Proc Am Thorac Soc 8: 535-540, 2011.
76. Tsoutsou PG and Koukourakis MI. Radiation pneumonitis and fibrosis: Mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66: 1281-1293, 2006.
77. Tzouvelekis A, Koliakos G, Ntolios P, Baira I, Bouros E, Oikonomou A, Zissimopoulos A, Kolios G, Kakagia D, Paspaliaris V, Kotsianidis I, Froudarakis M, and Bouros D. Stem cell therapy for idiopathic pulmonary fibrosis: A protocol proposal. J Transl Med 9: 182, 2011.
78. Tzouvelekis A, Ntolios P, and Bouros D. Stem cell treatment for chronic lung diseases. Respiration 85: 179-192, 2013.
79. Vorotnikova E, Rosenthal RA, Tries M, Doctrow SR, and Braunhut SJ. Novel synthetic SOD/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation. Radiat Res 173: 748-759, 2010.
80. Vujaskovic Z, Batinic-Haberle I, Rabbani ZN, Feng QF, Kang SK, Spasojevic I, Samulski TV, Fridovich I, Dewhirst MW, and Anscher MS. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiationinduced injury. Free Radic Biol Med 33: 857-863, 2002.
81. Wirsdorfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, Ludemann L, Stuschke M, and Jendrossek V. Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells. Radiat Oncol 9: 98, 2014.
82. Wirsdorfer F, de Leve S,Cappuccini F, Eldh T, MeyerAV, Gau E, Thompson LF, Chen NY, Karmouty-Quintana H, Fischer U, Kasper M, Klein D, Ritchey JW, Blackburn MR, Westendorf AM, Stuschke M, and Jendrossek V. Extracellular adenosine production by ecto-5'-nucleotidase (CD73) enhances radiationinduced lung fibrosis. Cancer Res 76: 3045-3056, 2016.
83. Yamaguchi M. Analysis of neurogenesis using transgenic mice expressing GFP with nestin gene regulatory regions. Chem Senses 30 Suppl 1: i117-i118, 2005.
84. Zeng L, Ou G, Itasaka S, Harada H, Xie X, Shibuya K, Kizaka-Kondoh S, Morinibu A, Shinomiya K, and Hiraoka M. TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis. Cancer Sci 99: 2327-2335, 2008.
85. Zhang L, Dong XW, Wang JN, Tang JM, Yang JY, Guo LY, Zheng F, Kong X, Huang YZ, and Chen SY. PEP-1-CAT-transduced mesenchymal stem cells acquire an enhanced viability and promote ischemia-induced angiogenesis. PLoS One 7: e52537, 2012.
86. Zhang ZY, Teoh SH, Chong MS, Schantz JT, Fisk NM, Choolani MA, and Chan J. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27: 126-137, 2009.
87. Zhao W and Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: Therapeutic implications. Curr Med Chem 16: 130-143, 2009.